sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove
Keywords:
Endothelial cell protein C receptor
Secretory group V phospholipase A2
Phosphatidylcholine
Lysophosphatidylcholine
Platelet activating factor
Publisher:
American Society of Hematology
Citation:
Lopez-Sagaseta J, Puy C, Tamayo I, Allende M, Cervero J, Velasco SE, et al. sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove. Blood 2012 Mar 22;119(12):2914-2921.
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.